1. Academic Validation
  2. Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9

Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9

  • Drug Des Devel Ther. 2018 Oct 9;12:3357-3368. doi: 10.2147/DDDT.S177126.
Xuchun Che 1 Rong Lu 1 2 Zheng Fu 2 Yajun Sun 3 Zhi-Feng Zhu 2 Jin-Ping Li 2 Song Wang 2 Jing Jia 2 Qing Wang 4 Zhi Yao 1
Affiliations

Affiliations

  • 1 Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Educational Ministry of China, School of Medical Sciences, Tianjin Medical University, Tianjin, People's Republic of China, [email protected]; [email protected].
  • 2 Department of Drug Development, Tianjin Kangzhe Pharmaceutical Company, Ltd., Tianjin, People's Republic of China.
  • 3 Department of Blood Transfusion, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
  • 4 Department of Clinical Laboratory, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Abstract

Background: Tyroserleutide (YSL) inhibits the growth and metastasis of human hepatocellular carcinoma (HCC). This paper studied the effect of YSL on metastasis of human HCC and investigated its mechanisms.

Methods: In vivo, experimental lung metastasis models of human HCC SK-HEP-1 cells in nude mice were established, and In vitro, the proliferation, adhesion and invasion of SK-HEP-1 cells were detected.

Results: In vivo, YSL significantly inhibited the metastasis of human HCC. In vitro, YSL significantly inhibited the proliferation, adhesion and invasion of SK-HEP-1 cells. Through analyses with Reverse transcription PCR (RT-PCR) and Western blot, we observed that YSL significantly inhibited the expressions of ICAM-1 in SK-HEP-1 cells. Through RT-PCR, Western blot and zymography methods, YSL was discovered to decrease the mRNA level, protein expression and activity of MMP-2 and -9 in SK-HEP-1 cells.

Conclusion: We concluded that YSL could inhibit tumor growth and metastasis of human HCC SK-HEP-1 cells.

Keywords

ICAM-1; MMP-2; MMP-9; adhesion; invasion; proliferation.

Figures
Products